Community/Retail

At the American Pharmacy Purchasing Alliance's PharmCon, Michael Castagna, PharmD, MBA, and CEO of Mannkind Corporation discussed the need for a larger focus on patient outcomes in order to better address the diabetes pandemic occurring in the United States.

Administering high doses of vitamin D over relatively short timeframes was associated with increased likelihood of toxicity, in a recent study.

In a recent study, researchers set out to identify the reasons why prescribers and pharmacists continue to prescribe NS β‐blockers despite the guidelines recommending against it.

If a governmental agency and/or a PBM nevertheless concludes that the arrangement is “gaming the system,” then the agency/PBM will likely be motivated to bring the arrangement to an end.

As seasonal allergy symptoms linger and summer travel season begins, the 2018 list of top-recommended over-the-counter products helps prepare consumers and their families to stay healthy during any summer adventure.

The CDC and local poison control centers offer useful guidance for best practices.

In this clip, Arsany Makkar, a PharmD candidate at the Rutgers University Ernest Mario School of Pharmacy, discusses the roles that pharmacists can play in the government.

A new study revealed no new or unexpected safety concerns associated with the diphtheria, tetanus, and acellular pertussis vaccine (DTaP).

At the American Pharmacy Purchasing Alliance’s PharmCon in Orlando, FL, experts with collaborative practice experience discussed why these pharmacist-physician partnerships are useful, and how they can effectively work.

Individuals who inject drugs are at an increased risk of developing invasive methicillin-resistant Staphylococcus aureus (MRSA).

During a presentation at the American Pharmacy Purchasing Alliance's Pharmacon in Orlando, FL, several panelists discussed the use of nutraceuticals in managing conditions like chronic pain.

Some 13,000 health care professionals from around the world convene each year at this popular meeting to discuss case studies, sympsia, oral presentations, and other forms of new research.

Change is needed to create a better working relationship between pharmacy benefit managers (PBMs) and independent pharmacies, according to a panel of experts at the American Pharmacy Purchasing Alliance (APPA) conference in Orlando, FL.

The deaths this week of Kate Spade and Anthony Bourdain have sparked a much-needed public discussion about mental health and suicide can be prevented.

As one of the most accessible health care providers, our patients come to us seeking advice not only for prescription medication and OTC questions but also on the big question: "How do I get healthy?"

An esteemed panel will deliberate more than 600 nominations.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Half of people who have diabetes eventually develop diabetic peripheral neuropathy, and the warning signs are sensory symptoms that start in the distant periphery and progressing in a characteristic 'glove and stocking' way.

As the 2018 midterm elections approach and the 115th Congress draws to a close, it is important for pharmacists to stay informed on legislative and regulatory issues that have the potential to affect their practice.

Point-of-care testing (POTC) increase patients' access to care and treatment. In 2 areas—influenza and streptococcal pharyngitis—POCT is available, but not used as often as it could be.

Kidney disease occurs along a continuum, and for people who have diabetes, the risk of developing kidney disease is significantly elevated.

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, explains the role that automation and technology plays in health care, and how it will affect the future of pharmacy practice.

Should emergency room clinicians use a breath-actuated nebulizer (BAN) or is a metered-dose inhaler (MDI) a better choice?

In this clip, Mark Neuenschwander, President of The Neuenschwander Company, discussed IV preparation errors and the importance of workflow technologies in reducing error rates.

Patricia C. Kienle, BSPharm, MPA, FASHP, director of accreditation and medication safety at Cardinal Health Innovative Delivery Solutions, discusses the impact of IV drug shortages and the importance of preparing for these shortages.

Fred Massoomi, PharmD, FASHP, Senior Director at Visante, explains how USP 800 regulations will drive the use of closed system transfer devices in health care.

Drug shortages aren’t going away anytime soon, which is why it’s important for pharmacies to put preparedness plans in place ahead of future IV shortages, according to an interactive discussion held this week at the ASHP Summer Meeting and Exhibition.